Performance Evaluation of Processing Methods for Ballistocardiogram Peak Detection

Effects of Ballistocardiogram Peak Detection Jitters on the Quality of Heart Rate Variability Features: A Simulation-Based Case Study in the Context of Sleep Staging

Heart rate variability (HRV) features support several clinical applications, including sleep staging, and ballistocardiograms (BCGs) can be used to unobtrusively estimate these features. Electrocardiography is the traditional clinical standard for HRV estimation, but BCGs and electrocardiograms (ECGs) yield different estimates for heartbeat intervals (HBIs), leading to differences in calculated HRV parameters. This study examines the viability of using BCG-based HRV features for sleep staging by quantifying the impact of these timing differences on the resulting parameters of interest. We introduced a range of synthetic time offsets to simulate the differences between BCG- and ECG-based heartbeat intervals, and the resulting HRV features are used to perform sleep staging. Subsequently, we draw a relationship between the mean absolute error in HBIs and the resulting sleep-staging performances. We also extend our previous work in heartbeat interval identification algorithms to demonstrate that our simulated timing jitters are close representatives of errors between heartbeat interval measurements. This work indicates that BCG-based sleep staging can produce accuracies comparable to ECG-based techniques such that at an HBI error range of up to 60 ms, the sleep-scoring error could increase from 17% to 25% based on one of the scenarios we examined.

Bed-Based Ballistocardiography: Dataset and Ability to Track Cardiovascular Parameters

BACKGROUND

The goal of this work was to create a sharable dataset of heart-driven signals, including ballistocardiograms (BCGs) and time-aligned electrocardiograms (ECGs), photoplethysmograms (PPGs), and blood pressure waveforms.

METHODS

A custom, bed-based ballistocardiographic system is described in detail. Affiliated cardiopulmonary signals are acquired using a GE Datex CardioCap 5 patient monitor (which collects ECG and PPG data) and a Finapres Medical Systems Finometer PRO (which provides continuous reconstructed brachial artery pressure waveforms and derived cardiovascular parameters).

RESULTS

Data were collected from 40 participants, 4 of whom had been or were currently diagnosed with a heart condition at the time they enrolled in the study. An investigation revealed that features extracted from a BCG could be used to track changes in systolic blood pressure (Pearson correlation coefficient of 0.54 +/- 0.15), dP/dtmax (Pearson correlation coefficient of 0.51 +/- 0.18), and stroke volume (Pearson correlation coefficient of 0.54 +/- 0.17).

CONCLUSION

A collection of synchronized, heart-driven signals, including BCGs, ECGs, PPGs, and blood pressure waveforms, was acquired and made publicly available. An initial study indicated that bed-based ballistocardiography can be used to track beat-to-beat changes in systolic blood pressure and stroke volume.

SIGNIFICANCE

To the best of the authors' knowledge, no other database that includes time-aligned ECG, PPG, BCG, and continuous blood pressure data is available to the public. This dataset could be used by other researchers for algorithm testing and development in this fast-growing field of health assessment, without requiring these individuals to invest considerable time and resources into hardware development and data collection.

A Unified Methodology for Heartbeats Detection in Seismocardiogram and Ballistocardiogram Signals

This work presents a methodology to analyze and segment both seismocardiogram (SCG) and ballistocardiogram (BCG) signals in a unified fashion. An unsupervised approach is followed to extract a template of SCG/BCG heartbeats, which is then used to fine-tune temporal waveform annotation. Rigorous performance assessment is conducted in terms of sensitivity, precision, Root Mean Square Error (RMSE) and Mean Absolute Error (MAE) of annotation. The methodology is tested on four independent datasets, covering different measurement setups and time resolutions. A wide application range is therefore explored, which better characterizes the robustness and generality of the method with respect to a single dataset. Overall, sensitivity and precision scores are uniform across all datasets ( p > 0.05 from the Kruskal–Wallis test): the average sensitivity among datasets is 98.7%, with 98.2% precision. On the other hand, a slight yet significant difference in RMSE and MAE scores was found ( p < 0.01 ) in favor of datasets with higher sampling frequency. The best RMSE scores for SCG and BCG are 4.5 and 4.8 ms, respectively; similarly, the best MAE scores are 3.3 and 3.6 ms. The results were compared to relevant recent literature and are found to improve both detection performance and temporal annotation errors.

A Contact-Free, Ballistocardiography-Based Monitoring System (Emfit QS) for Measuring Nocturnal Heart Rate and Heart Rate Variability: Validation Study

Background

Heart rate (HR) and heart rate variability (HRV) measurements are widely used to monitor stress and recovery status in sedentary people and athletes. However, effective HRV monitoring should occur on a daily basis because sparse measurements do not allow for a complete view of the stress-recovery balance. Morning electrocardiography (ECG) measurements with HR straps are time-consuming and arduous to perform every day, and thus compliance with regular measurements is poor. Contact-free, ballistocardiography (BCG)-based Emfit QS is effortless for daily monitoring. However, to the best of our knowledge, there is no study on the accuracy of nocturnal HR and HRV measured via BCG under real-life conditions.

Objective

The aim of this study was to evaluate the accuracy of Emfit QS in measuring nocturnal HR and HRV.

Methods

Healthy participants (n=20) completed nocturnal HR and HRV recordings at home using Emfit QS and an ECG-based reference device (Firstbeat BG2) during sleep. Emfit QS measures BCG by a ferroelectret sensor installed under a bed mattress. HR and the root mean square of successive differences between RR intervals (RMSSD) were determined for 3-minute epochs and the sleep period mean.

Results

A trivial mean bias was observed in the mean HR (mean –0.8 bpm [beats per minute], SD 2.3 bpm, P=.15) and Ln (natural logarithm) RMSSD (mean –0.05 ms, SD 0.25 ms, P=.33) between Emfit QS and ECG. In addition, very large correlations were found in the mean values of HR (r=0.90, P<.001) and Ln RMSSD (r=0.89, P<.001) between the devices. A greater amount of erroneous or missing data (P<.001) was observed in the Emfit QS measurements (28.3%, SD 14.4%) compared with the reference device (1.1%, SD 2.3%). The results showed that 5.0% of the mean HR and Ln RMSSD values were outside the limits of agreement.

Conclusions

Based on the present results, Emfit QS provides nocturnal HR and HRV data with an acceptable, small mean bias when calculating the mean of the sleep period. Thus, Emfit QS has the potential to be used for the long-term monitoring of nocturnal HR and HRV. However, further research is needed to assess reliability in HR and HRV detection.